Research & Development

Product development

Research and development is conducted in-house and with the company’s partners. In addition, Enzymatica is involved in the funding of research projects at several universities. In  the last years, work was intensified with university researchers to investigate the function of ColdZyme against upper respiratory viruses, including variants of the SARS-CoV-2 virus. Research and development is led by Enzymatica's staff in Lund and Reykjavik, with the help of external consultants, laboratories and universities. 

Research and development at Enzymatica is divided into three tracks:

1. Evaluate the possibilities of barrier technology
2. Expand the scientific documentation
3. Develop new products

Patent protection

Enzymatica has patent protection for the cod enzyme (ZT) which is one of the key components in ColdZyme. The patent covers most of the world's leading cold markets, including USA, China, Japan, Europe and Australia until the end of 2036.